• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18900-5T
Device Problem Application Program Problem: Parameter Calculation Error (1449)
Patient Problems Loss of consciousness (2418); Hypoglycemic Shock (4575)
Event Date 05/02/2021
Event Type  Injury  
Manufacturer Narrative
The device has not been returned/received to date.If the device is received, a supplemental report will be submitted with the investigation results.We are unable to determine if any product condition could have contributed to the reported hospitalization and hypoglycemia.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including communicating with the pdm, deployment, delivering fluid, occlusion detection, and freedom from hazard alarms.
 
Event Description
It was reported that the patient was taken to the hospital via ambulance due to low blood glucose (bg) levels of 3.6 mmol/l (64.8 mg/dl) and fainting, while using the omnipod device.The patient's personal diabetes manager (pdm) meter was reading incorrectly, which drove the patient to deliver more insulin than needed resulting in an insulin shock through overdose.The patient was administered glucose orally in form of gel.
 
Manufacturer Narrative
Customer reports inaccurate bg readings.During the bg meter test, it was noted that the device was set to calibration code 8.Customer reports specifically that they are using freestyle lite strips that require code 16.Based on the strip simulation tester, blood glucose readings were found to be within specification and record successfully into the device memory.During the bg meter strip insertion verification test, the pdm recognized the activities and registered readings immediately.Data downloaded from the device indicate all but two measurements on the date of occurrence for the medical event were performed by the bg meter, the remainder were manual entries.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
MDR Report Key11767393
MDR Text Key248787891
Report Number3004464228-2021-06537
Device Sequence Number1
Product Code LZG
UDI-Device Identifier10385081120166
UDI-Public(01)10385081120166(11)180904(10)L60981
Combination Product (y/n)N
PMA/PMN Number
K192659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup
Report Date 05/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number18900-5T
Device Catalogue NumberDAT450
Device Lot NumberL50058
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/25/2021
Date Manufacturer Received06/30/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age14 YR
-
-